AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Genflow Biosciences Plc

2.1p +$0.15 (+7.64%)
LSE · 16 Sep 2026 11:35 UTC
Previous Close
2.17p
Day Range
2.05p2.25p
Year Range
0.9p3.12p
Market Cap
11.89M
AVG Volume
1.48M
Trailing/Forward PE
-6.17/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
-400K-200K0200K400K22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
25 Q4292.8K
25 Q3292.8K
25 Q2122.55K
25 Q1122.55K
24 Q4-396.06K
23 Q4-97.03K
23 Q3-97.03K
23 Q297.03K
23 Q197.03K
22 Q40
Net Income (GBP)
-1.5M-1M-500K022 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q4-339.97K
25 Q3-339.97K
25 Q2-368.81K
25 Q1-368.81K
24 Q4-531.49K
23 Q4-1.01M
23 Q3-503.58K
23 Q2-621.54K
23 Q1-310.77K
22 Q4-561.53K
Operating Income (GBP)
-1.5M-1M-500K022 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q4-339.97K
25 Q3-339.97K
25 Q2-368.81K
25 Q1-368.81K
24 Q4-371.25K
23 Q4-983.08K
23 Q3-503.65K
23 Q2-815.48K
23 Q1-310.7K
22 Q4-1.05M
EBITDA (GBP)
-1.5M-1M-500K022 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q4-339.73K
25 Q3-339.73K
25 Q2-368.51K
25 Q1-368.51K
24 Q4-531.2K
23 Q4-982.46K
23 Q3-503.34K
23 Q2-815.07K
23 Q1-310.5K
22 Q4-1.05M
Cash Flows (GBP)
-1M-750K-500K-250K022 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q4-299.89K
25 Q3-299.89K
25 Q2-418.4K
25 Q1-418.4K
24 Q4-441.38K
23 Q4-809.18K
23 Q3-404.59K
23 Q2-848.72K
23 Q1-424.36K
22 Q4-593.53K
EPS (GBP)
-0-0-0-0022 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
23 Q4-0
23 Q3-0
23 Q2-0
23 Q1-0
22 Q4-0
Expenses (GBP)
-500K0500K1M1.5MR&DSG&ACapex22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q4267.88K
25 Q3267.88K
25 Q2824.29K
25 Q1824.29K
24 Q4401.97K
23 Q4980.37K
23 Q3698.08K
23 Q2819.59K
23 Q1617.58K
22 Q41.13M
Cash & Debt (GBP)
01M2M3M22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q4111.79K
25 Q3111.79K
25 Q2279.44K
25 Q1279.44K
24 Q4278.68K
23 Q4683.97K
23 Q3683.97K
23 Q21.51M
23 Q11.51M
22 Q42.36M
Debt ratios
00.511.522 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Debt ratios by quarter
PeriodDebt ratios
25 Q40.08
25 Q30.07
25 Q20.12
25 Q10.12
24 Q40.1
23 Q40.26
23 Q30.26
23 Q20.69
23 Q10.71
22 Q41.29
Margins
0%50%100%150%23 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Margins by quarter
PeriodMargins
25 Q4100%
25 Q3100%
25 Q2100%
25 Q1100%
24 Q4100%
23 Q4100.64%
23 Q3100%
23 Q299.57%
23 Q1100%
Return on Capital
-200%-100%0%100%200%22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Return on Capital by quarter
PeriodReturn on Capital
25 Q461.73%
25 Q361.73%
25 Q2121.72%
25 Q1121.72%
24 Q4131.88%
23 Q4-138.74%
23 Q3-69.37%
23 Q2-36.17%
23 Q1-18.09%
22 Q4-23.73%
Shares Outstanding
0200M400M600M22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q4469.14M
25 Q3469.14M
25 Q2384.28M
25 Q1384.28M
24 Q4351.05M
23 Q4292.51M
23 Q3292.44M
23 Q2292.51M
23 Q1292.63M
22 Q4292.51M
Book Value Per Share (GBP)
-0000.010.010.0122 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
23 Q40
23 Q30
23 Q20.01
23 Q10.01
22 Q40.01
Total Assets (GBP)
01M2M3M22 Q423 Q123 Q223 Q323 Q424 Q425 Q125 Q225 Q325 Q4
GENF.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q4452.39K
25 Q3452.39K
25 Q2468.38K
25 Q1468.38K
24 Q4385.91K
23 Q41.07M
23 Q31.07M
23 Q21.91M
23 Q11.91M
22 Q42.62M
Genflow Biosciences Plc
GENF.L
Stockpicker

Video analysis: GENF.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GENF.L

Apple expected to unveil first foldable iPhone as new CEO Ternus takes stage

proactiveinvestors.com · 8 Sep 2026

Apple expected to unveil first foldable iPhone as new CEO Ternus takes stage

Apple Inc (NASDAQ:AAPL, XETRA:APC) is set to unveil its first foldable iPhone alongside a refreshed Pro lineup, in John Ternus's first major product launch...

Caterpillar surges as AI demand drives record revenue

proactiveinvestors.com · 4 Aug 2026

Caterpillar surges as AI demand drives record revenue

Caterpillar Inc (NYSE:CAT, XETRA:CAT) shares jumped 11% to $923 in pre-market trading on Tuesday after booming demand for power-generation equipment helped...

Shell sells solar and wind operations to France's TotalEnergies

proactiveinvestors.com · 3 Aug 2026

Shell sells solar and wind operations to France's TotalEnergies

Shell PLC (LSE:SHEL, NYSE:SHEL) has struck a deal to sell its European onshore renewables business to France's TotalEnergies. The FTSE 100 oil giant said it...

Dow Jones and Nasdaq climbs as big tech drive gains ahead of busy Wall Street week

proactiveinvestors.com · 3 Aug 2026

Dow Jones and Nasdaq climbs as big tech drive gains ahead of busy Wall Street week

Wall Street stocks opened the week firmly higher, as Microsoft and Amazon put some further Big Tech weight behind the rally that started last week.  The Dow...

Micron shares rise on Anthropic AI infrastructure partnership

proactiveinvestors.com · 22 Jun 2026

Micron shares rise on Anthropic AI infrastructure partnership

Micron Technology Inc (NASDAQ:MU) shares rose more than 4% on Monday after the company announced a strategic agreement with Anthropic covering AI...

Genflow to present beagle gene therapy data at longevity summit

proactiveinvestors.com · 17 Jun 2026

Genflow to present beagle gene therapy data at longevity summit

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the longevity research company, has been invited to present results from its SLAB clinical study...

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.